Work

Plasma and Pleural Fluid Pharmacokinetics of Erlotinib and its Active Metabolite OSI-420 in Patients With Non–Small-Cell Lung Cancer With Pleural Effusion

Year: 2011

Type: article

Source: Clinical Lung Cancer

DOI: 10.1016/j.cllc.2011.06.004

Authors: Katsuhiro Masago, Yosuke Togashi, Masahide Fukudo, Tomohiro Terada, Kaoru Irisa, Yuichi Sakamori, Young Hak Kim, Tadashi Mio, Ken-ichi Inui, Michiaki Mishima

Institutions: Kyoto University, National Cancer Center Hospital East, Kyoto Pharmaceutical University

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Japan Society for the Promotion of Science

Awards: Individualized molecular targeted therapy based on pharmacogenomics and pharmacokinetic optimization, Construction of administration algorithm of novel oral molecular-targeted anti-cancer drugs based on the clarificationof interindividual differences of pharmacokinetics and pharmacodynamics

OpenAlex ID: W1973191130

FWCI: 2.48

Cites: 27

Cited by: 23

Related to: 10